Related Experiment Video

Updated: Jul 19, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

428

Shaping the tumor immune microenvironment of SCLC: Mechanisms, and opportunities for immunotherapy

Yunfei Chen1, Hui Li1, Yun Fan1

  • 1Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China; Postgraduate Training base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, Zhejiang 310022, China.

Cancer Treatment Reviews
|August 14, 2023
PubMed

Insights

Small-cell lung cancer (SCLC) immunotherapy shows promise, but its tumor immune microenvironment (TIME) poses challenges. Understanding SCLC

Area of Science:

  • Oncology
  • Immunology
  • Genomics

Background:

  • Small-cell lung cancer (SCLC) is an aggressive neuroendocrine tumor with a poor prognosis.
  • Immunotherapy offers potential for SCLC treatment, but patient responses are often limited by the tumor immune microenvironment (TIME).

Purpose of the Study:

  • To comprehensively characterize the SCLC TIME.
  • To elucidate the mechanisms driving SCLC TIME formation.
  • To identify strategies for improving SCLC immunotherapy efficacy.

Main Methods:

  • Review of multi-omics data (genomics, epigenomics, metabolomics) related to SCLC.
  • Analysis of the interplay between tumor biology and the TIME in SCLC.
  • Synthesis of current knowledge on SCLC TIME features and regulatory mechanisms.

Main Results:

  • SCLC exhibits a unique TIME that influences immunotherapy response.
  • Genomic, epigenomic, and metabolomic factors significantly shape the SCLC TIME.
  • Multi-omics approaches provide deep insights into TIME regulation in SCLC.

Conclusions:

  • Characterizing the SCLC TIME is critical for advancing immunotherapy.
  • Targeting TIME-modulating mechanisms presents future therapeutic opportunities.
  • Further research is needed to overcome immunotherapy challenges in SCLC.
Keywords:
ImmunotherapySmall cell lung cancerTumor immune microenvironment

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.5K
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

849

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
557
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K